PEDIATRIC CANCER FOUNDATION

Programs
Killer T-Cell Immunotherapy Research
THE CHILDREN'S HOSPITAL OF PHILADELPHIA RECIEVED A GRANT IN THE FISCAL YEAR FOR KILLER T-CELL IMMUNOTHERAPY RESEARCH BEING CONDUCTED TO COMBATE CANCER.GeographiesNot indicatedDatesJul 1, 2023 – Jun 30, 2024Source990No causes providedNo populations provided–$500KPCF Developmental Therapeutics Research
COLUMBIA UNIVERSITY IRVING MEDICAL CENTER WAS GIVEN A GRANT FOR RESEARCH ON PCF DEVELOPMENTAL THERAPEUTICS TO COMBAT RECURING CANCERS OR CANCERS THAT DO NOT RESPOND TO TRADITIONAL TREATMENT METHODS.GeographiesNot indicatedDatesJul 1, 2023 – Jun 30, 2024Source990No causes providedNo populations provided–$230KTargeted Immunotherapy in Oncology
THE WESTCHESTER MEDICAL CENTER WAS PROVIDED A GRANT IN CONCECTION WITH THEIR PROGRAM FOR REDUCING THE BURDEN OF ONCOLOGIC CHEMOTHERAPY AND RADIATION EXPOSURE UTILIZING TARGETED IMMUNOTHERAPY IN CHILDREN ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMA.GeographiesNot indicatedDatesJul 1, 2023 – Jun 30, 2024Source990No causes providedNo populations provided–$150K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)